14 Scopus citations

Abstract

Persons with opioid use disorder (OUD) hospitalized with severe, injection-related infections (SIRI) are frequently hospitalized for the duration of IV antibiotic treatment due to concerns regarding their eligibility for outpatient parenteral antimicrobial therapy (OPAT), which is the standard of care for prolonged IV antibiotic courses for patients without drug use. As part of a pilot study, a novel, integrated care model was developed where patients with OUD and SIRI receive addiction consultation and buprenorphine induction while hospitalized, followed by ongoing management in an outpatient clinic that combines office-based opioid treatment with buprenorphine pharmacotherapy and counseling services with OPAT. Through three illustrative case vignettes the outpatient model is described along with challenges, lessons learned and future directions.

Original languageEnglish
Article number105760
JournalPreventive Medicine
Volume128
DOIs
StatePublished - Nov 2019

Bibliographical note

Funding Information:
University of Kentucky College of Medicine Multidisciplinary Value Program, Office of the Vice President for Research, and the Center for Clinical and Translational Science , grant number UL1TR001998 .

Funding Information:
University of Kentucky College of Medicine Multidisciplinary Value Program, Office of the Vice President for Research, and the Center for Clinical and Translational Science, grant number UL1TR001998.

Publisher Copyright:
© 2019 Elsevier Inc.

Keywords

  • Buprenorphine
  • Endocarditis
  • Intravenous
  • Opiate-related disorders
  • Substance abuse
  • Vascular access devices

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model'. Together they form a unique fingerprint.

Cite this